Chronic Pain Following Treatment for Cancer: The Role of Opioids
Open Access
- 1 December 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 8 (6) , 567-575
- https://doi.org/10.1634/theoncologist.8-6-567
Abstract
Learning Objectives: After completing this course, the reader will be able to: Explain the principles of chronic pain management in cancer patients. Discuss the principles of opioid use in patients with chronic pain. Recognize and prevent substance-related disorders in cancer patients treated with opioids. Access and take the CME test online and receive one hour of AMA PRA category 1 credit at CME.TheOncologist.com Opioids are the most effective analgesics for severe pain and the mainstay of acute and terminal cancer pain treatments. In those settings, opioids are used over a limited time period so that opioid tolerance, if it develops, is relatively easy to overcome, and other problems of opioid use, including substance abuse, are unlikely to be problematic. As cancer treatments improve and increasing numbers of cancer patients experience long remissions, chronic pain due to cancer, or to cancer treatment, becomes a clinical problem that oncologists will encounter. Chronic pain differs from acute and terminal pain in several fundamental respects. In the case of chronic pain, functional restoration is a predominant goal of treatment. Because it is often due to neuronal damage, the pain may be particularly sensitive to nonopioid medications, and opioids can be reserved for refractory pain. If opioids are chosen, tolerance, dependence, and addiction can interfere, and safeguards designed to minimize these must be built into the treatment plan. This article reviews the principles of chronic opioid therapy for non-cancer pain and how these principles may be adapted for patients with chronic pain due to cancer.Keywords
This publication has 40 references indexed in Scilit:
- Chronic Morphine Induces Downregulation of Spinal Glutamate Transporters: Implications in Morphine Tolerance and Abnormal Pain SensitivityJournal of Neuroscience, 2002
- Endocytosis of the Mu Opioid Receptor Reduces Tolerance and a Cellular Hallmark of Opiate WithdrawalNeuron, 2001
- An international survey of cancer pain characteristics and syndromesPain, 1999
- Long-term opioid therapy: Assessment of consequences and risksJournal of Pain and Symptom Management, 1996
- Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain servicePAIN®, 1996
- The WHO Analgesic Ladder for Cancer Pain ManagementJAMA, 1995
- Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective studyPain, 1995
- Mechanisms of hyperalgesian and morphine tolerance: a current view of their possible interactionsPain, 1995
- Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic painPain, 1995
- A validation study of the WHO method for cancer pain reliefCancer, 1987